---
title: "Cathay Biotech: Net profit of 137 million yuan in the first quarter of 2025, a year-on-year increase of 30.11%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238047797.md"
description: "Cathay Biotech announced that its revenue for the first quarter of 2025 was 776 million yuan, a year-on-year increase of 13.33%; net profit was 137 million yuan, a year-on-year increase of 30.11%"
datetime: "2025-04-29T11:49:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238047797.md)
  - [en](https://longbridge.com/en/news/238047797.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238047797.md)
generator: "portal-rs"
---

# Cathay Biotech: Net profit of 137 million yuan in the first quarter of 2025, a year-on-year increase of 30.11%

Cathay Biotech announced that its revenue for the first quarter of 2025 was 776 million yuan, a year-on-year increase of 13.33%; net profit was 137 million yuan, a year-on-year increase of 30.11%

### Related Stocks

- [688065.CN](https://longbridge.com/en/quote/688065.CN.md)

## Related News & Research

- [Chugin Capital Partners’ investment head Ishimoto joins POTLUCK AWARD’26 final panel as judge](https://longbridge.com/en/news/296545904.md)
- [LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study](https://longbridge.com/en/news/296106866.md)
- [09:03 ETPlayOn Sports Brings the Nation's Top High School Football Games to Fans Nationwide with 2026 MaxPreps Game of the Week](https://longbridge.com/en/news/296621737.md)
- [DAZN becomes Indiana Pacers’ exclusive regional streaming partner for 2026-27 season](https://longbridge.com/en/news/296538501.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**